SG

Shailendra Gupta

Active Director Director DIN 11283641
DIN 11283641 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailendra Gupta

Data last updated:

Shailendra Gupta is a Director at Medos Health India Private Limited (since 2025).

DIN 11283641
Primary Designation Director
First Appointment 12 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medos Health India Private Limited U62013DL2025PTC455249
Director12 Sep 20252025Active

Board colleagues of Shailendra Gupta

NameDINCompanyDesignation
Nishi Parween11283982Medos Health India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medos Health India Private Limited
Premium access

Shareholding and investment profile for Shailendra Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailendra Gupta

Shailendra Gupta currently holds 1 directorship: Medos Health India Private Limited (Director, since 12 Sep 2025).

Shailendra Gupta was first appointed on 12 Sep 2025 as Director at Medos Health India Private Limited.

The current boards of Shailendra Gupta's companies include Nishi Parween (Medos Health India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available